Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Citi
Baxter
Chubb
Argus Health
Federal Trade Commission
Merck
McKesson

Generated: April 19, 2018

DrugPatentWatch Database Preview

Anchen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?

ANCHEN PHARMS has twenty-five approved drugs.

There are two tentative approvals on ANCHEN PHARMS drugs.

Summary for Anchen Pharms
US Patents:0
Tradenames:21
Ingredients:21
NDAs:25

Drugs and US Patents for Anchen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anchen Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205784-001 Jun 9, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Anchen Pharms DIVALPROEX SODIUM divalproex sodium TABLET, EXTENDED RELEASE;ORAL 078445-001 Feb 26, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Anchen Pharms LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 201374-001 Dec 26, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Anchen Pharms LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091360-001 Oct 4, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Daiichi Sankyo
Johnson and Johnson
Dow
Medtronic
McKinsey
Fish and Richardson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.